These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8838461)

  • 1. Comparison of [3H]YM060 binding to native and cloned rat 5-HT3 receptors.
    Akuzawa S; Miyake A; Miyata K; Fukutomi H
    Eur J Pharmacol; 1996 Jan; 296(2):227-30. PubMed ID: 8838461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of [3H]YM060, a potent and selective 5-HT3 receptor radioligand, in the cerebral cortex of rats.
    Akuzawa S; Miyata K; Fukutomi H
    Eur J Pharmacol; 1995 Jul; 281(1):37-42. PubMed ID: 8566114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
    J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of 5-hydroxytryptamine3 receptors in murine brain and ileum using the novel radioligand [3H]RS-42358-197: evidence for receptor heterogeneity.
    Bonhaus DW; Wong EH; Stefanich E; Kunysz EA; Eglen RM
    J Neurochem; 1993 Nov; 61(5):1927-32. PubMed ID: 8229003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylimidazolidin-2-one derivatives as selective 5-HT3 receptor antagonists and refinement of the pharmacophore model for 5-HT3 receptor binding.
    Heidempergher F; Pillan A; Pinciroli V; Vaghi F; Arrigoni C; Bolis G; Caccia C; Dho L; McArthur R; Varasi M
    J Med Chem; 1997 Oct; 40(21):3369-80. PubMed ID: 9341912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
    Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
    Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding.
    Kilpatrick GJ; Jones BJ; Tyers MB
    Nature; 1987 Dec 24-31; 330(6150):746-8. PubMed ID: 3696238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.
    Wainscott DB; Cohen ML; Schenck KW; Audia JE; Nissen JS; Baez M; Kursar JD; Lucaites VL; Nelson DL
    Mol Pharmacol; 1993 Mar; 43(3):419-26. PubMed ID: 8450835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of 5-hydroxytryptamine3 receptors from porcine brain.
    Fletcher S; Barnes NM
    Br J Pharmacol; 1997 Oct; 122(4):655-62. PubMed ID: 9375961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that the atypical 5-HT3 receptor ligand, [3H]-BRL46470, labels additional 5-HT3 binding sites compared to [3H]-granisetron.
    Steward LJ; Ge J; Bentley KR; Barber PC; Hope AG; Lambert JJ; Peters JA; Blackburn TP; Barnes NM
    Br J Pharmacol; 1995 Sep; 116(2):1781-8. PubMed ID: 8528560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological properties of quinoxaline derivatives as a new class of 5-HT3 receptor antagonists.
    Lasheras B; Berjón A; Montañés R; Roca J; Romero G; Ramírez MJ; Del Río J
    Arzneimittelforschung; 1996 Apr; 46(4):401-6. PubMed ID: 8740088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New 2-piperazinylbenzimidazole derivatives as 5-HT3 antagonists. Synthesis and pharmacological evaluation.
    Orjales A; Mosquera R; Labeaga L; Rodes R
    J Med Chem; 1997 Feb; 40(4):586-93. PubMed ID: 9046349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of YM060, a potent and selective 5-hydroxytryptamine3 receptor antagonist, in rabbit nodose ganglion and N1E-115 neuroblastoma cells.
    Ito H; Hidaka K; Miyata K; Kamato T; Nishida A; Honda K
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1127-32. PubMed ID: 1469624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT3 receptors.
    Cappelli A; Anzini M; Vomero S; Canullo L; Mennuni L; Makovec F; Doucet E; Hamon M; Menziani MC; De Benedetti PG; Bruni G; Romeo MR; Giorgi G; Donati A
    J Med Chem; 1999 May; 42(9):1556-75. PubMed ID: 10229626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Hydroxytryptamine3 receptor and regulation of gastric emptying in rats.
    Ito C; Isobe Y; Tsuchida K; Higuchi S
    Arch Int Pharmacodyn Ther; 1996; 331(2):203-18. PubMed ID: 8937630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of serotonin (5-HT)3-receptor antagonists YM060, YM114 (KAE-393), ondansetron and granisetron on 5-HT4 receptors and gastric emptying in rodents.
    Miyata K; Yamano M; Kamato T; Akuzawa S
    Jpn J Pharmacol; 1995 Nov; 69(3):205-14. PubMed ID: 8699628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological differences and similarities between the native mouse 5-HT3 receptor in N1E-115 cells and a cloned short splice variant of the mouse 5-HT3 receptor expressed in HEK 293 cells.
    Brüss M; Molderings GJ; Bönisch H; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):225-33. PubMed ID: 10543422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrimination in 5-HT(3) receptor binding in murine brain and cultured cell preparations.
    Zhang ZJ; Trivedi BL; de Paulis T; Schmidt DE; Hewlett WA
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):123-32. PubMed ID: 11819030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological analysis of G-protein activation mediated by guinea-pig recombinant 5-HT1B receptors in C6-glial cells: similarities with the human 5-HT1B receptor.
    Pauwels PJ; Wurch T; Palmier C; Colpaert FC
    Br J Pharmacol; 1998 Jan; 123(1):51-62. PubMed ID: 9484854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
    Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
    Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.